Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Epertinib |
Trade Name | |
Synonyms | S-222611|S222611|S222611 |
Drug Descriptions |
Epertinib (S-222611) is a dual inhibitor of EGFR and ERBB2 (HER2), leading to decreased kinase activity and potentially inhibiting growth of tumors expressing EGFR or ERBB2 (HER2) (PMID: 24837299, PMID: 30196106, PMID: 31892325). |
DrugClasses | EGFR Inhibitor (Pan) 62 HER2 Inhibitor 42 |
CAS Registry Number | 908305-13-5 |
NCIT ID | C166884 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Epertinib | Epertinib | 0 | 0 |
Epertinib + Trastuzumab | Epertinib Trastuzumab | 0 | 0 |